Global Continuous Positive Airway Pressure (CPAP) Market Research Report: Forecast (2022-2027)

Market Definition

A Continuous Positive Airway Pressure (CPAP) is a medical device that operates on spontaneous ventilation & gas exchange. The device compressor generates an uninterrupted stream of pressurized air across the air passage, improving oxygenated airflow via tube & mask. CPAP are often intended for people dealing with sleep-related breathing disorders, including obstructive sleep apnea (OSA), to keep their airways clear during sleep.

The device is also beneficial in treating preterm infants having underdeveloped lungs. CPAP is also known for maintaining a Positive End-Expiratory Pressure (PEEP), increasing the surface area of the alveolus, decreasing atelectasis, improving V/Q (Ventilation/Perfusion) matching, & enhancing oxygenation, among others.

Market Insights

The Global Continuous Positive Airway Pressure (CPAP) Market is projected to grow at a CAGR of around 7.70% during the forecast period, i.e., 2022-27. The market is driven by the rapidly increasing economic burden & challenges faced by the healthcare industry, especially after the advent of Covid-19, demonstrating a flooding number of patients with a high prevalence of respiratory diseases. It has paved the way for the broader adoption of devices like CPAP devices to address their conditions across healthcare settings. With the massive influx of patients globally & the high demand for CPAP, leading players are witnessing a presentation of growth opportunities to increase their production & distribution capacities and cater to the burgeoning requirements across different healthcare facilities globally. 

Besides, an alarming rise in sleep apnea patients, especially across countries like the US, Canada, and others, is demonstrating a dire need for more CPAP devices. In the same line, people with chronic disorders like obesity & hypertension are more susceptible to developing obstructive sleep apnea, thereby passively influencing the demand for Continuous Positive Airway Pressure (CPAP) devices and stimulating the market. 

• According to the World Health Organization (WHO), Sleep apnea accounts for nearly one billion of the global burden of sleeping disorders. Sleep apnea, being common in adults & older individuals, is said to have infected 1 to 6% of adults.
• According to a report published by The Global Impact of Respiratory Disease, 24% of men aged 30–60 had obstructive sleep apnea.

Moreover, the continuous technological advancements in CPAP Devices, like Auto-adjusting devices that regulate the air pressure automatically, resulting in lesser assistance & enhanced comfort, further amplify the market growth. Such a substantial market ascension lies in the capability of these devices to store vast data, leading to improved clinical outcomes with minimal human errors by healthcare professionals.

Market Segmentation

Based on End Users:

• Hospitals & Clinics
• Nursing Homes
• Elderly Care Centers
• Home-Use

Among all, Hospitals & Clinics acquired a considerable share in the Global Continuous Positive Airway Pressure (CPAP) Market in recent years and are anticipated to prevail in the same trend during the forecast period. This growth attributes to a swift rise in the geriatric population, propelling emergency & long-term hospitalization requirements, demonstrating an escalation in the need for CPAP devices.

Likewise, the high birth rates, alongside the number of premature or newborn infants encountering undergrown lungs or indicating respiratory issues, are the other consumers of CPAP devices, instigating healthcare facilities like hospitals & clinics to stock such devices. As a result, the market is hinting toward the presence of lucrative opportunities for the leading players across the sector, stimulating the overall market trajectory through 2027. 

• According to the American Academy of Sleep Medicine (AASM), consistent adherence to CPAP reduces the risk of 30-day hospital readmission among the geriatric population with comorbid obstructive sleep apnea & cardiovascular disease.

Based on Type of Disorder:

• Obstructive Sleep Apnea (OSA)
• Chronic Obstructive Respiratory Disorder
• Neuromuscular Disorder
• Asthma

Here, Obstructive Sleep Apnea (OSA) is anticipated to dominate the Global Continuous Positive Airway Pressure (CPAP) Market with the largest share during the forecast period. This dominance attributes to the wide adoption of CPAP devices used for treating Sleep Apnea and eliminating snoring. The doctors for such patients may recommend using a CPAP device. Backed by the growing prevalence of these health disorders, the market is set to witness an upswing in need & generate lucrative opportunities for the leading players to increase their production & distribution capacities to cater to the burgeoning demands globally.

• According to research by the American Academy of Sleep Medicine, nearly 30 million adults in the U.S. have obstructive sleep apnea, a chronic disease that involves the frequent collapse of the upper airway during sleep and is said to be found in 40%-60% of people diagnosed with cardiovascular disease.

With the growing prevalence of OSA and spreading awareness among people about this syndrome, demonstrating frequent pauses in breathing during sleep accompanied by loud snoring, with the potential to cause critical health conditions, are playing a prominent role in augmenting the demand for CPAPs. Since such disorders require suitable & immediate treatment, the market shall observe an upsurge in demand during the forecast years.

Regional Projection

Geographically, the Global Continuous Positive Airway Pressure (CPAP) Market expands across:

• North America
• South America
• Europe
• Middle East & Africa
• Asia-Pacific

North America acquired the largest market share in recent years & is projected to prevail in the same trend during the forecast period. This dominance attributes to the massive investments & safety guidelines issued by the governments of different countries in the region throughout the healthcare sector to strengthen the industry and cater to the burgeoning patient influx having respiratory disorders.

Besides, numerous research & development activities to bring innovations in the diagnosis, treatment, & care of patients suffering from such disorders is another aspect promulgating the demand for CPAP devices and stimulating the industry across North America. Additionally, well-defined regulatory guidelines for medical equipment to reduce any unprecedented disruption to the emergency services are also boosting the demand for CPAP devices, especially across countries like the US & Canada.

Moreover, since the region has the most significant number of OSA patients, the adoption of CPAP devices is elevating rapidly & generating growth opportunities for the leading players to increase their offerings and cater to the burgeoning requirements. Besides, increasing awareness among people regarding advanced innovations, including continuous positive airway pressure machines swiftly augments the market growth during the forecast period.

Regulatory Landscape in the Global Continuous Positive Airway Pressure (CPAP) Market

• Recently, the US FDA (Food & Drug Association) made additions to the safety communication to provide the latest information about medical device reports (MDRs) received in the second quarter of 2022. The update was in response to the breakdown of the polyester-based polyurethane (PE-PUR) foam used in the Philips CPAP machines enclosed in the June 2021 recall. In case of a recall, the FDA continues to monitor companies' actions related to the repair or replacement of impacted devices until the brand has met all requirements concerning the conduct of their recall and the Medical Device Quality System regulation.
• The American Academy of Sleep Medicine laid down guidelines & protocols to incorporate virtual care & consultation, aiming to address declining sleep studies and procedural volume.

CPAP devices must comply with International/European Union standards which comprise:

• IEC 60601-1: General Requirements for Safety of Medical Electrical Equipment.
• EN ISO 80601-2-70:2015: Particular requirements for basic safety and performance of sleep apnea or breathing therapy equipment. 
  • Along with the above standards, CE Marking, Independent Laboratory Testing, Cleaning/Infection Control, Operating Instructions and Modes, Dimensions, connectors, tubing, Size, Shape, and Form of Buttons/Controls on the Device must be taken care of while considering the production of CPAP devices.

Recent Developments in the Global Continuous Positive Airway Pressure (CPAP) Market

• In 2021, Eakin Healthcare acquired Armstrong Medical, specializing in respiratory care products, where the acquisition seems to embark on an expansion into a new therapeutic area.
• Philips & Cognizant planned their collaboration to create additional end-to-end solutions in July 2021. The incorporation develops comprehensive digital health solutions allowing healthcare organizations & life sciences businesses to offer better patient care & move clinical trials along.
• In 2019, ResMed introduced additional types such as the AirFitF30, a full-face mask with a minimal-contact cushion, and the AirFitN30i and P30i, a nasal and pillow mask attached to the top of the head, respectively. Among the top businesses selling continuous positive airway pressure (CPAP) devices are Corporation, Circadiance, and ResMed.
• In 2017, the smallest Positive Airway Pressure (PAP) device was introduced by RoyalPhilips, called DreamStation Go, to make traveling easier for people with obstructive respiratory disorders. The business innovates respiratory products to meet the needs of people with neuromuscular disorders and COPD.
• Again, to treat apnea patients, ResMed introduced the AirMini, the smallest CPAP in the world, in April 2017.
• Royal Philips a world leader in health technology, & the Dutch SAZ group inked a strategic collaboration deal in February 2021 that covers patient monitoring, observation, and self-management throughout their care.

Market Dynamics

Key Driver: Rising Prevalence of Sleep Disorders & Chronic Respiratory Diseases

The high prevalence of sleep apnea among people due to the growing cases of diabetes, cardiovascular diseases, & other illnesses worldwide is one of the prominent reasons behind the mounting demand for CPAP devices. The same aspect is stimulating the market & generating growth opportunities for the leading players to increase their production capacities and cater to the burgeoning demands globally.

Key Questions Answered in the Market Research Report:

1. What are the overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares) of the Global Continuous Positive Airway Pressure (CPAP) Market?
2. What are the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Continuous Positive Airway Pressure (CPAP) Market?
4. Who are the key competitors, their key strengths & weaknesses, and how do they perform in the Global Continuous Positive Airway Pressure (CPAP) Market based on the competitive benchmarking matrix?
5. What are the key results derived from surveys conducted during the Global Continuous Positive Airway Pressure (CPAP) Market study?

Frequently Asked Questions